1045 related articles for article (PubMed ID: 29073341)
41. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
42. Translational metabolomics in cancer research.
Snyder NW; Mesaros C; Blair IA
Biomark Med; 2015; 9(9):821-34. PubMed ID: 26329905
[TBL] [Abstract][Full Text] [Related]
43. Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods.
Dong H; Zhang A; Sun H; Wang H; Lu X; Wang M; Ni B; Wang X
Mol Biosyst; 2012 Apr; 8(4):1206-21. PubMed ID: 22282765
[TBL] [Abstract][Full Text] [Related]
44. UHPLC-QTOF-MS/MS-SPE-NMR: A Solution to the Metabolomics Grand Challenge of Higher-Throughput, Confident Metabolite Identifications.
Bhatia A; Sarma SJ; Lei Z; Sumner LW
Methods Mol Biol; 2019; 2037():113-133. PubMed ID: 31463842
[TBL] [Abstract][Full Text] [Related]
45. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.
Dona AC; Coffey S; Figtree G
Eur J Prev Cardiol; 2016 Oct; 23(15):1578-89. PubMed ID: 27103630
[TBL] [Abstract][Full Text] [Related]
46. Metabolomics: moving to the clinic.
Nordström A; Lewensohn R
J Neuroimmune Pharmacol; 2010 Mar; 5(1):4-17. PubMed ID: 19399626
[TBL] [Abstract][Full Text] [Related]
47. Advantages and Pitfalls of Mass Spectrometry Based Metabolome Profiling in Systems Biology.
Aretz I; Meierhofer D
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128910
[TBL] [Abstract][Full Text] [Related]
48. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy.
Dunn WB; Broadhurst DI; Atherton HJ; Goodacre R; Griffin JL
Chem Soc Rev; 2011 Jan; 40(1):387-426. PubMed ID: 20717559
[TBL] [Abstract][Full Text] [Related]
49. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li Y; Song X; Zhao X; Zou L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
[TBL] [Abstract][Full Text] [Related]
50. NMR metabolomics identifies over 60 biomarkers associated with Type II Diabetes impairment in db/db mice.
Mora-Ortiz M; Nuñez Ramos P; Oregioni A; Claus SP
Metabolomics; 2019 Jun; 15(6):89. PubMed ID: 31179513
[TBL] [Abstract][Full Text] [Related]
51. Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine.
Frédérich M; Pirotte B; Fillet M; de Tullio P
J Med Chem; 2016 Oct; 59(19):8649-8666. PubMed ID: 27295417
[TBL] [Abstract][Full Text] [Related]
52. Targeted urine metabolomics with a graphical reporting tool for rapid diagnosis of inborn errors of metabolism.
Steinbusch LKM; Wang P; Waterval HWAH; Stassen FAPM; Coene KLM; Engelke UFH; Habets DDJ; Bierau J; Körver-Keularts IMLW
J Inherit Metab Dis; 2021 Sep; 44(5):1113-1123. PubMed ID: 33843072
[TBL] [Abstract][Full Text] [Related]
53. Metabolomics in Alzheimer's disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology.
González-Domínguez R; Sayago A; Fernández-Recamales Á
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1071():75-92. PubMed ID: 28189423
[TBL] [Abstract][Full Text] [Related]
54. [Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].
Yoshida M; Nishiumi S; Azuma T
Rinsho Byori; 2015 Apr; 63(4):450-6. PubMed ID: 26536778
[TBL] [Abstract][Full Text] [Related]
55. Challenges in applying chemometrics to LC-MS-based global metabolite profile data.
Want E
Bioanalysis; 2009 Jul; 1(4):805-19. PubMed ID: 21083139
[TBL] [Abstract][Full Text] [Related]
56. Metabolomics in multiple sclerosis.
Bhargava P; Calabresi PA
Mult Scler; 2016 Apr; 22(4):451-60. PubMed ID: 26754801
[TBL] [Abstract][Full Text] [Related]
57. Individualized metabolomics: opportunities and challenges.
Misra B
Clin Chem Lab Med; 2020 Jun; 58(6):939-947. PubMed ID: 30951498
[TBL] [Abstract][Full Text] [Related]
58. Metabolomics for Investigating Physiological and Pathophysiological Processes.
Wishart DS
Physiol Rev; 2019 Oct; 99(4):1819-1875. PubMed ID: 31434538
[TBL] [Abstract][Full Text] [Related]
59. Metabolomics and cardiovascular biomarker discovery.
Rhee EP; Gerszten RE
Clin Chem; 2012 Jan; 58(1):139-47. PubMed ID: 22110018
[TBL] [Abstract][Full Text] [Related]
60. Capillary electrophoresis mass spectrometry as a tool for untargeted metabolomics.
García A; Godzien J; López-Gonzálvez Á; Barbas C
Bioanalysis; 2017 Jan; 9(1):99-130. PubMed ID: 27921456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
